Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Modulating these pathways is therefore an area requiring careful characterisation in research
Evaluating the Relationship between Circadian Rhythms and Sleep, Metabolic and Cardiovascular Disorders: Current Clinical Evidence in Human Studies
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Another update recommends considering glucagonlike peptide1 [GLP1] receptor agonists for highrisk patients with CVD who have type 2 diabetes, which is in line with the findings of recently published clinical trials, including the LEADER (ClinicalTrials.gov identifier: NCT01179048) trials 2
US$ 21.60
US$ 26.63
US$ 26.05
US$ 21.80
US$ 20.58
US$ 22.71
US$ 20.33
US$ 25.86
US$ 27.86
US$ 22.31
